Study identifies potential drug targets for muscular dystrophy treatments

January 9, 2017

Myotonic dystrophy type I (MD1) is a common form of muscular dystrophy associated with muscle wasting, weakness, and myotonia. These symptoms are linked to the accumulation of toxic gene transcripts in muscle cells that result from abnormal gene splicing.

Recent studies have indicated that muscle cell health and function depend critically on the pathways that support and autophagy, a process that helps degrade and recycle cellular debris.

This week in the JCI, a study led by Perrine Castets at the University of Basel has demonstrated that pharmacological treatments targeting AMPK and mTOR signaling pathways, which regulate energy balance and autophagy in cells, improve the symptoms of MD1 in a mouse model. They initially observed that AMPK and mTORC1 pathways were disrupted in from the MD1 model mice.

Further investigation revealed that autophagy was also impaired in MD1 muscle, and this impairment contributed to dystrophy-like symptoms in the mice. When MD1 mice were treated with a drug that activated AMPK signaling, they displayed improvements in muscle function as well as reductions in abnormal gene splicing. Treating MD1 mice with rapamycin, a clinically-approved drug that activates mTORC1 signaling, also reduced signs of muscle pathology.

These findings identify targets in the AMPK and mTORC1 pathways that may be potential therapies for MD1.

Explore further: New target may slow disease progression in Duchenne muscular dystrophy

More information: Marielle Brockhoff et al, Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I, Journal of Clinical Investigation (2017). DOI: 10.1172/JCI89616

Related Stories

Uncleaned cells mean weak muscles

April 23, 2013

The protein complex mTORC1 promotes muscle growth. However, should this complex remain constantly active, it impairs the ability of the cells to self-clean, causing myopathy. Scientists working with Markus Rüegg, Professor ...

Recommended for you

'CYCLOPS' algorithm spots daily rhythms in cells

April 25, 2017

Humans, like virtually all other complex organisms on Earth, have adapted to their planet's 24-hour cycle of sunlight and darkness. That circadian rhythm is reflected in human behavior, of course, but also in the molecular ...

Discovery offers new hope to repair spinal cord injuries

April 24, 2017

Scientists at the Gladstone Institutes created a special type of neuron from human stem cells that could potentially repair spinal cord injuries. These cells, called V2a interneurons, transmit signals in the spinal cord to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.